National Pharmacovigilance Assessment of Oral Adverse Events Following COVID-19 Vaccination in Germany (2020-2023)
Within the limitations of passive surveillance data, this study highlights the need for further research on oral AEs using self-controlled case-series designs for clinically significant events. Integrating oral AEs into vaccine safety monitoring could improve postmarketing surveillance, while validated AEs may warrant inclusion in product information for transparency.
Authors
- Abanoub Riad (ORCID: https://orcid.org/0000-0001-5918-8966)
Institutions
- Masaryk University (CZ)
Publication Details
- Journal
- International Dental Journal
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1016/j.identj.2025.100906
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.39